CSIMarket
 
Dexcom Inc   (DXCM)
Other Ticker:  
 
   Industry ../Industry/industry_growth_rates.php?netcfw&ind=804"> Medical Equipment & Supplies
   Sector  Healthcare
 
Price: $113.9300 $-0.63 -0.550%
Day's High: $115.45 Week Perf: 2.95 %
Day's Low: $ 113.06 30 Day Perf: -5.19 %
Volume (M): 2,624 52 Wk High: $ 539.06
Volume (M$): $ 298,930 52 Wk Avg: $168.01
Open: $114.50 52 Wk Low: $67.11



 Market Capitalization (Millions $) 47,406
 Shares Outstanding (Millions) 416
 Employees 6,400
 Revenues (TTM) (Millions $) 2,910
 Net Income (TTM) (Millions $) 341
 Cash Flow (TTM) (Millions $) -410
 Capital Exp. (TTM) (Millions $) 365

Dexcom Inc


   Company Address: 6340 Sequence Drive San Diego 92121 CA
   Company Phone Number: 200-0200   Stock Exchange / Ticker: NASDAQ DXCM
   DXCM is expected to report next financial results on April 27, 2023.


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
SENS   -7.84%    
• View Complete Report
   



Acacia Research Corp

Extremely challenging financial reporting period for ACTG in the most recent fiscal period

For the fiscal time-frame closing December 31 2022 ACTG slipped into shortfall of $-0.37 per share compare to $1.06 a year before and EPS fell from $0.02 per share from the previous financial reporting period.

Sales dropped sharply by -79.259 % to $13.12 millions from $63.26 millions in the corresponding financial reporting period a year before and sequentially Sales fell by -17.364 % from $15.88 millions.

Revlon Inc

The company reported a -4.129 %, reduction in Sales, amid the most recent fiscal period

Lower Sales led to diminishing Returns in the fourth quarter of 2022 earnings season, Sales fell by -4.129 % to $589.80 millions and deficit per share was at $-3.18 in contrast to $0.18 per share realized in the financial reporting period a year prior.

Akero Therapeutics Inc

Akero Therapeutics Inc added some good surprise for the stock market, exhibiting a significant growth in fourth quarter of 2022 earnings season with operating deficit of $-25.42 millions

The Major Pharmaceutical Preparations industry experts begin to scrutinize the fourth quarter of 2022 performance. Presently they follow operating deficit of $-25.42 millions, from the Akero Therapeutics Inc , which has not cited any revenue still, for the respective October to December 31 2022 reporting season.

Ssr Mining Inc

Severe hit for the company in the fourth quarter of 2022

For the fiscal period closing December 31 2022 company income per share dropped by -30.1 % of $0.30 per share compare to $0.42 a year prior and income per share turned positive from $-0.12 per share from the prior quarter.

Sales went down sharply by -79.217 % to $306.38 millions from $1.47 billions in the same quarter a year prior and sequentially Sales surged by 83.87 % from $166.63 millions.

Markforged Holding Corporation

Critical quarter for MKFG during the October to December 31 2022 period

For the October to December 31 2022 interval MKFG lost money of $-0.05 per share compare to $-0.05 a year ago and earnings per share improved from $-0.12 per share from the preceding quarter.

Sales dropped sharply by -55.841 % to $29.66 millions from $67.18 millions in the similar quarter a year ago and sequentially Sales improved by 17.677 % from $25.21 millions.






 

Dexcom Inc 's Segments
 
 
• View Complete Report


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

FRST's Profile

Stock Price

FRST's Financials

Business Description

Fundamentals

Charts & Quotes

FRST's News

Suppliers

FRST's Competitors

Customers & Markets

Economic Indicators

FRST's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071